Flagship’s next genetic meds startup has $50M for transfer at a critical protein stop


Alltrna, a biotech startup founded by Flagship Pioneering, is developing a new type of medicines based on a form of RNA called transfer RNA, or tRNA. The company’s scientists say that this approach offers the potential to treat a wide range of diseases, both rare and common.

Leave a Reply